Present and Future Uses of Hemoperfusion with Sorbents

Keyphrases

• Sorbent 100%
• Hemoperfusion 100%
• Hemodialysis 20%
• Coma 20%
• Cerebrospinal Fluid 20%
• Drug Elimination 20%
• Charcoal 20%
• Hepatic Encephalopathy 20%
• Whole-body 10%
• Clinical Application 10%
• Urea 10%
• Creatinine 10%
• Extraction Efficiency 10%
• Amino Acids 10%
• Blood Flow 10%
• Untreated Patients 10%
• Adriamycin 10%
• Cyclic Adenosine Monophosphate (cAMP) 10%
• Methotrexate 10%
• Anticancer Drugs 10%
• Plasma Fluid 10%
• Activated Charcoal 10%
• Cancer Chemotherapy 10%
• Drug Profile 10%
• Clearance Rate 10%
• Uremia 10%
• Resin 10%
• Body Clearance 10%
• Uremic Toxins 10%
• Pharmacokinetic Model 10%
• Fulminant Hepatic Failure 10%
• Plasma Drug Concentration 10%
• Uremic Patients 10%
• Incomplete Knowledge 10%
• Toxic Molecules 10%
• Elimination Rate 10%
• Sorption 10%
• Plasma Extraction 10%
• Middle Molecules 10%

Medicine and Dentistry

• Hemoperfusion 100%
• Sorbent 100%
• Hemodialysis 20%
• Coma 20%
• Cerebrospinal Fluid 20%
• Drug Elimination 20%
• Hepatic Encephalopathy 20%
• Creatinine 10%
• Uremia 10%
• Pharmacokinetics 10%
• Cyclic AMP 10%
• Methotrexate 10%
• Amino Acid 10%
• Blood Flow 10%
• Doxorubicin 10%
• Anticarcinogen 10%
• Activated Charcoal 10%
• Cancer Chemotherapy 10%
• Drug Analysis 10%
• Clearance 10%
• Uremic Toxin 10%
• Fulminant Hepatic Failure 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Sorbent 100%
• Hemoperfusion 100%
• Hemodialysis 20%
• Coma 20%
• Hepatic Encephalopathy 20%
• Creatinine 10%
• Syndrome 10%
• Elimination 10%
• Anticarcinogen 10%
• Doxorubicin 10%
• Amino Acid 10%
• Cyclic AMP 10%
• Methotrexate 10%
• Drug Concentration 10%
• Uremia 10%
• Cancer Chemotherapy 10%
• Fulminant Hepatic Failure 10%
• Elimination Rate Constant 10%
• Uremic Toxin 10%
• Pharmacokinetics 10%
• Activated Carbon 10%